Medication info
Glida Tablet (Gliclazide)

Glida Tablet (Gliclazide)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Hanpung Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201904477 · Approved 2019.07.01 · Insurance code 658106520

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching to this medicine from another oral hypoglycemic agent, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has initially been successfully managed during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is indicated when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is combined with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Hanpung Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be used alone or in conjunction with metformin or sulfonylureas when blood sugar control is insufficient with oral hypoglycemic agents or insulin therapy. This helps to improve blood sugar control more effectively.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching to this medicine from another oral hypoglycemic agent, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has initially been successfully managed during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is indicated when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is combined with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Additionally, individuals who are allergic to this medication or its components, sulfonylureas, or sulfonamides should not take it. Patients with severely impaired liver or kidney function have not been experienced with this medication, so switching to insulin therapy is recommended in such cases. Women who are pregnant or may become pregnant, as well as nursing women, should not take this medication. Patients with severe infections, those undergoing surgery, or individuals with severe trauma should preferably receive insulin therapy. Caution is advised in cases of gastrointestinal disorders such as diarrhea or vomiting, as they may impair food absorption and increase the risk of hypoglycemia. This medication contains lactose, hence it should not be taken by patients with lactose intolerance or specific genetic problems. During the first week of taking this medication, there is a higher risk of hypoglycemia, so careful monitoring of blood sugar levels is essential. Particularly, elderly patients, those with poor nutritional status or who skip meals, those with imbalanced physical activity and carbohydrate intake, frequent alcohol consumers, and individuals with impaired kidney or liver function should exercise extra caution. Furthermore, the risk of hypoglycemia increases if this medication is overdosed, if there are endocrine disorders, or if other medications are being taken simultaneously. Symptoms of hypoglycemia can vary and may include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, or decreased consciousness, so medical personnel should be notified immediately if these symptoms occur. This medication contains a dye called Yellow No. 5, so those allergic to this ingredient should be cautious. Hypoglycemia may occur with this medication, leading to various symptoms such as headaches, severe hunger, vomiting, fatigue, confusion, drowsiness, or decreased consciousness. Hypoglycemia is typically resolved quickly by consuming foods that contain sugar. Gastrointestinal symptoms such as blurred vision, nausea, abdominal pain, and diarrhea may also occur. Liver function abnormalities or blood-related problems may rarely occur, necessitating regular check-ups. Allergic reactions can present as itching, rash, or hives, and in severe cases may progress to breathing difficulties or shock, requiring immediate medical attention. Additionally, side effects such as hair loss and weight gain have been reported. It is important to take this medication regularly for blood sugar control, along with adhering to dietary and exercise regimens. In the event of hypoglycemic symptoms, immediate consumption of sugar is necessary, and carrying sugar at all times is advisable. During treatment, regular monitoring of blood sugar and urine tests is recommended to confirm drug efficacy, and dosage adjustments or changes in treatment methods may be needed as necessary. Caution is warranted when driving or operating machinery due to the risk of accidents from hypoglycemia. In situations of acute stress, blood sugar control may become more difficult, so treatment methods may need to change according to physician's instructions. This medication may interact with other drugs, so it's essential to inform healthcare providers of any other medications being taken. Particularly, caution is advised when taken alongside drugs that affect the enzymes that break down this drug in the liver. Additionally, using this medication with insulin, some anti-inflammatory drugs, antibiotics, or anticoagulants may affect blood sugar control. Some medications like beta-blockers may mask the symptoms of hypoglycemia, requiring additional caution. It is safer for pregnant or nursing women not to use this medication. This could harm the fetus, and during nursing, the medication can be passed to the baby. If necessary, switching to insulin therapy or discontinuing breastfeeding is recommended. For children under 18, the safety and efficacy of this medication have not been established, so it's advisable not to use it. Elderly patients may have reduced kidney function, requiring careful adjustment of this medication's dosage. Severe hypoglycemia can occur with overdose, so immediate contact with medical personnel is required for necessary emergency treatment. Following an overdose, measures such as inducing vomiting, blocking absorption of the drug, or gastric lavage may be necessary. If hypoglycemic coma is suspected, rapid injection of glucose should be administered, followed by close monitoring of blood glucose levels for 1 to 2 days.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, cardiac arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased hepatic enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. A storage temperature between 1°C and 30°C is advisable to safely maintain the drug's efficacy.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.